Novel triple therapy for hemorrhagic ascites caused by endometriosis: A case report

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

BACKGROUND: Massive hemorrhagic ascites caused by endometriosis is exceedingly rare, and the treatment strategy remains controversial. Here, we report a case of endometriosis with massive hemorrhagic ascites treated with a novel triple therapy including conservative surgery, gonadotropin-releasing hormone agonist, and then dienogest. CASE SUMMARY: A 28-year-old nulliparous patient was admitted to Shengjing Hospital of China Medical University, and exploratory laparoscopy was performed. A total of 9500 mL of brown ascites was aspirated from the pelvic cavity, the bilateral ovaries strongly adhered to the posterior of the uterus and were fixed to the pelvic floor, and endometriotic cysts were not observed in either ovary. The pelvic and abdominal peritonea were covered with patchy red, white, and brown endometriotic lesions and defects. Partial surgical resection of endometriotic lesions on the peritoneum was performed while we simultaneously collected multiple peritoneal biopsies. The final pathological diagnosis was endometriosis coupled with hemorrhagic necrotic tissue. CONCLUSION: Postoperative injection of gonadotropin-releasing hormone agonist was provided three times, followed by dienogest administration, and we will continue to follow up with this ongoing treatment.

Cite

CITATION STYLE

APA

Han, X., & Zhang, S. T. (2020). Novel triple therapy for hemorrhagic ascites caused by endometriosis: A case report. World Journal of Clinical Cases, 8(23), 6206–6212. https://doi.org/10.12998/wjcc.v8.i23.6206

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free